ADIPOTIDE

Weight Loss & MetabolicResearch Only

Extremely limited research with no published human studies. Represents an interesting proof-of-concept for targeted fat cell elimination, but evidence base is essentially nonexistent.

Primarily investigated by obesity researchers exploring novel mechanisms for permanent fat reduction and vascular biologists studying tissue-specific targeting approaches.

FDA Status
Research Only

Since Feb 2026

Evidence
Limited data
Studies

0 total

What is ADIPOTIDE?

This experimental compound represents one of the more unusual approaches to weight management research, designed to selectively kill fat cells rather than simply shrink them. Adipotide works by cutting off blood supply to adipose tissue, causing the fat cells to die through natural cellular death processes. Research remains confined to laboratory settings, with most investigators focused on understanding its tissue-targeting capabilities.

The peptide binds to prohibitin, a protein found on the surface of blood vessels that feed white fat tissue. By attaching to these vessels and disrupting their function, adipotide essentially starves fat cells of their blood supply, leading them to undergo apoptosis - the body's normal process for eliminating damaged or unwanted cells. Think of it as selectively cutting power lines to specific neighborhoods, causing those areas to shut down while leaving surrounding tissue intact.

Reported Benefits

Targeted fat reduction
Adipose tissue targeting

Regulatory Status

Research OnlyEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.